Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis
Primary Purpose
Carcinoma, Hepatocellular, Liver Neoplasms, Digestive System Neoplasms
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
MR-guided Laser Interstitial Thermal Therapy System
Sponsored by
About this trial
This is an interventional treatment trial for Carcinoma, Hepatocellular focused on measuring MRI guided Laser Therapy, Laser Interstitial Thermal Therapy, Magnetic Resonance Thermal Imaging, Liver Metastasis
Eligibility Criteria
Inclusion Criteria:
- Patients 18 years of age or older
- Patients with liver metastasis, originating from colon and liver cancer and proved by histological analysis
- Patient that are scheduled for a surgical resection of part of the liver,
- Patient having a liver metastasis, originating from colon and rectal cancer, smaller or equal to 3 cm
- Patients having the liver metastasis at a distance of at least 1 cm or from the hepatic capsule or/and from a vascular structure
Exclusion Criteria:
- Patients younger than 18 years old
- Patients presenting contra indication for MRI studies
- Patient presenting contra indication to liver surgery
- Patients who already had other interstitial treatment on the targeted lesion
Sites / Locations
- Hospital Cochin
Outcomes
Primary Outcome Measures
Accuracy of predicted lesion geometry to histologically measured dimensions
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00392366
Brief Title
Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis
Official Title
The Clinical Evaluation of the Laser Interstitial Thermal Therapy (LITT ), Under "Real Time" MRI Guidance, for the "Minimal Invasive" Treatment of Liver Metastasis - a Phase IIa Mono-centric Study, Without Direct Benefice to the Patient
Study Type
Interventional
2. Study Status
Record Verification Date
December 2009
Overall Recruitment Status
Completed
Study Start Date
July 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2008 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
BioTex, Inc.
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine if the, MR guided, laser interstitial thermal therapy (LITT) treatment technique can be safety and efficiently used for the human liver metastasis
Detailed Description
This new "minimally invasive" technique has been tested so far, with success, on animal brain and prostate tumors. LITT has also tested with success by other teams for the treatment of liver metastasis.
The main purpose of this study is to determine if the Visualase, MR guided, laser interstitial thermal therapy device can be safely and efficiently used for the treatment of human liver metastasis originating from the colon and rectal primary tumors.
As secondary objectives for this clinical study is to explore the tolerance of the treatment and its contra indications.
The clinical trial will include a statistical sample of 25 patients and will run over a period of 24 months. The inclusion period will be of 12 months and the patients will be followed up during a period of 7 days after the intervention.
The clinical trial will be performed at the Cochin University Hospital of Paris and the patients will be coming from the oncology / surgery departments of the hospital.
The patients recruited for this study are those who developed several liver metastasis and are planned for the a surgical resection for part of the liver (where metastasis are located). Prior to the surgical resection, a LITT procedure will be performed on one of the metastasis. After the surgical resection histological analysis will be elaborated to compare the real necrosis volume created by the LITT procedure to the expected predicted volume.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Carcinoma, Hepatocellular, Liver Neoplasms, Digestive System Neoplasms
Keywords
MRI guided Laser Therapy, Laser Interstitial Thermal Therapy, Magnetic Resonance Thermal Imaging, Liver Metastasis
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
25 (Anticipated)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
MR-guided Laser Interstitial Thermal Therapy System
Primary Outcome Measure Information:
Title
Accuracy of predicted lesion geometry to histologically measured dimensions
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients 18 years of age or older
Patients with liver metastasis, originating from colon and liver cancer and proved by histological analysis
Patient that are scheduled for a surgical resection of part of the liver,
Patient having a liver metastasis, originating from colon and rectal cancer, smaller or equal to 3 cm
Patients having the liver metastasis at a distance of at least 1 cm or from the hepatic capsule or/and from a vascular structure
Exclusion Criteria:
Patients younger than 18 years old
Patients presenting contra indication for MRI studies
Patient presenting contra indication to liver surgery
Patients who already had other interstitial treatment on the targeted lesion
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul Legmann, M.D.
Organizational Affiliation
Cochin Hosptial, Paris, France
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Cochin
City
Paris
ZIP/Postal Code
75679
Country
France
12. IPD Sharing Statement
Learn more about this trial
Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis
We'll reach out to this number within 24 hrs